236 related articles for article (PubMed ID: 9534010)
1. Added benfluorex in obese insulin-requiring type 2 diabetes.
Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
[TBL] [Abstract][Full Text] [Related]
2. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
[TBL] [Abstract][Full Text] [Related]
3. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
[TBL] [Abstract][Full Text] [Related]
4. Effects of benfluorex in obese patients with metabolic disorders.
di Martino G; Federico P; Mattera E; Jacono G
Br J Clin Pract; 1989 Jun; 43(6):201-8. PubMed ID: 2597599
[TBL] [Abstract][Full Text] [Related]
5. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
[TBL] [Abstract][Full Text] [Related]
7. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
[TBL] [Abstract][Full Text] [Related]
9. Effects of orlistat on obesity-related diseases - a six-month randomized trial.
Guy-Grand B; Drouin P; Eschwège E; Gin H; Joubert JM; Valensi P
Diabetes Obes Metab; 2004 Sep; 6(5):375-83. PubMed ID: 15287931
[TBL] [Abstract][Full Text] [Related]
10. Effects of sibutramine in overweight, poorly controlled Chinese female type 2 diabetic patients: a randomised, double-blind, placebo-controlled study.
Wang TF; Pei D; Li JC; Tsai WC; Tsai CC; Yao CY; Chang ET; Hsieh MC; Su KY; Kuo SW
Int J Clin Pract; 2005 Jul; 59(7):746-50. PubMed ID: 15963197
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
12. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
13. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
[TBL] [Abstract][Full Text] [Related]
14. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
[TBL] [Abstract][Full Text] [Related]
15. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
[TBL] [Abstract][Full Text] [Related]
16. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
17. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo.
Roger P; Auclair J; Drain P
J Diabetes Complications; 1999; 13(2):62-7. PubMed ID: 10432168
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.
Velussi M; Monte AD; Cernigoi AM
J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014
[TBL] [Abstract][Full Text] [Related]
19. [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].
Leblanc H; Marre M; Billault B; Passa P
Diabete Metab; 1987; 13(6):613-7. PubMed ID: 3329125
[TBL] [Abstract][Full Text] [Related]
20. [Cross-over study of benfluorex and a hypolipemic agent in diet-resistant types IV and II b hyperlipemia (author's transl)].
Graisely B; Cloarec M
Sem Hop; 1980 Jun 18-25; 56(25-28):1221-5. PubMed ID: 6256875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
